Search
AVID-200
go.drugbank.com/drugs/DB18454InvestigationalAVID-200 is an Anti-transforming growth factor beta (TGF-β) trap fusion protein.
Tildacerfont
go.drugbank.com/drugs/DB18545InvestigationalTildacerfont is a corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring
1-benzylimidazole
go.drugbank.com/drugs/DB04581Experimental1-benzylimidazole, an N-imidazole derivative, has been shown to have strong cardiotonic activity.
Diethyltryptamine
go.drugbank.com/drugs/DB01460ExperimentalIllicitDiethyltryptamine (DET) is an orally active hallucinogenic agent and a substituted form of tryptamine.
alpha-D-quinovopyranose
go.drugbank.com/drugs/DB03773ExperimentalThe pyranose form of D-quinovose with an α-configuration at the anomeric position .
OMS906
go.drugbank.com/drugs/DB17722InvestigationalOMS906 is a humanized Igg4 monoclonal antibody against mannan-binding lectin-associated serine protease-3 (MASP-3) currently being developed by Omeros.
DLO6001
go.drugbank.com/drugs/DB05178ExperimentalDL6001 is developed by DanioLabs using proprietary zebrafish technology to treat Parkinson’s disease symptoms including sialorrhoea and hyperhidrosis.
Efavirenz
go.drugbank.com/drugs/DB00625ApprovedInvestigationalEfavirenz is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to prevent HIV transmission for those exposed to materials associated with
Mebenil
go.drugbank.com/drugs/DB14728ExperimentalAn obsolete fungicide used to control various pathogens on cereals and seed potatoes.
VG161
go.drugbank.com/drugs/DB18469InvestigationalVG161 is an oncolytic virus therapy under investigation for the treatment of cholangiocarcinoma.